ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

In Brief: Fauci, Lenfant, Bulkley Rumored For NIH Job; Jimmie Holland Gets Psychiatric Oncology Chair

July 28, 1989

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

January 28, 2011

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002